Entry Detail



General Information

Database ID:exR0015571
RNA Name:TUBA1B
RNA Type:mRNA
Chromosome:chr12
Starnd:-
Coordinate:
Start Site(bp):49127782End Site(bp):49131397
External Links:ENSG00000123416



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ADIPOR1
chr1
202940826
202958572
-
AKIRIN1
chr1
38991276
39006059
+
AEN
chr15
88621337
88632281
+
ADCY5
chr3
123282296
123449758
-
ALDOA
chr16
30064164
30070457
+
AK2
chr1
33007940
33080996
-
ADRM1
chr20
62302093
62308862
+
ABRACL
chr6
139028745
139043302
+
ACSS2
chr20
34872146
34927962
+
AGFG2
chr7
100539203
100568220
+
ACTN4
chr19
38647649
38731589
+
AGBL5
chr2
27042364
27070622
+
ABI2
chr2
203328239
203447728
+
AC008878.3
chr19
7382834
7470241
+
ADGRG6
chr6
142301854
142446266
+
ACVR2B
chr3
38453890
38493142
+
AC120057.2
chr17
7240427
7244635
-
AC138811.2
chr16
18788063
18801519
-
ABHD14A-ACY1
chr3
51974706
51989183
+
ADD1
chr4
2843857
2930076
+
AC004922.1
chr7
99325879
99394653
+
ADSL
chr22
40346500
40390463
+
ACTG1
chr17
81509971
81523847
-
ADA
chr20
44619522
44652233
-
AC007192.1
chr19
18153158
18178117
+
AC007040.2
chr2
70939318
70995336
-
AC015813.2
chr17
57989038
58007246
-
ADAR
chr1
154582057
154628013
-
AC011448.1
chr19
19516227
19536076
+
AL136454.1
chr1
192716132
192716653
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-103a-3p
chr5
168560904
168560926
-
hsa-miR-106a-5p
chrX
134170244
134170266
-
hsa-miR-221-3p
chrX
45746180
45746202
-
hsa-miR-302c-3p
chr4
112648366
112648388
-
hsa-miR-652-3p
chrX
110055389
110055409
+
hsa-miR-1291
chr12
48654494
48654517
-
hsa-miR-3654
chr7
133034860
133034878
-
hsa-miR-4707-5p
chr14
22956998
22957020
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005618.1
chr5
141326210
141329357
+
AC007952.4
chr17
19112000
19112636
-
AC012485.1
chr2
238231684
238255633
+
AC016876.2
chr17
7581964
7584086
-
AC022167.2
chr16
8848105
8860456
+
AC023509.1
chr12
53441741
53467528
+
AC026362.1
chr12
122975320
122982907
+
AC069281.2
chr7
100572232
100578700
-
AC087190.3
chr16
9104848
9113181
+
AC104461.1
chr1
200333193
200478669
+
AC124067.3
chr8
37559992
37567477
+
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
AL049543.1
chr6
28587378
28591747
+
AL118516.1
chr22
46761894
46762563
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.